Switch to:
More From Other Websites
Generics Giants Like Teva and Mylan May Now Join the Buy-and-Raise Craze Oct 09 2015
NBIX: Positive Results for Kinect-3; NDA for NBI-98854 in 2016; increasing PT to $70 Oct 08 2015
Neurocrine Tardive Dyskinesia Drug Hits, Stock Jumps Oct 08 2015
Teva Announces Approval of Three-Times-A-Week COPAXONE® 40 mg/mL in Russia for the Treatment of... Oct 08 2015
Mallinckrodt (MNK) Issues Fiscal 2016 Guidance, Shares Up Oct 07 2015
The Zacks Analyst Blog Highlights: CVS Health, Amgen, Eli Lilly, AbbVie and Teva Pharmaceutical Oct 07 2015
FDA Approves Alkermes' Schizophrenia Treatment Aristada Oct 06 2015
4 Pharma Stocks Gaining from High Pricing Power Oct 06 2015
Stocks Move Back Into Red as Biotech Sells Off Again Oct 06 2015
Teva Reinforces Focus on Advancing Multiple Sclerosis Treatment at 31st ECTRIMS Congress Oct 06 2015
Acorda, Allergan Make Surprise Deal On Ampyra Patent Oct 05 2015
Pharma Deals in Latin America Continue, Teva to Buy Rimsa Oct 02 2015
Business Watch Oct 01 2015
Teva Pharma Makes a $2.3 Billion Acquisition Oct 01 2015
Massive, unexpected drug price increases are happening all the time Oct 01 2015
Teva making its second multibillion-dollar buy this year Oct 01 2015
Teva Pharm to buy Mexican drugmaker Rimsa for $2.3 bln Oct 01 2015
Teva Pharm to buy Mexican drugmaker Rimsa for $2.3 bln Oct 01 2015
Teva to buy Mexico's Rimsa for $2.3 bln Oct 01 2015
Teva to acquire Mexico’s Rimsa for $2.3 billion Oct 01 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership